VivioMD logo

VivioMD Review

7.1
★★★★☆3.6/5

GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: flat-priced GLP-1 care with a refund if you are not approved

VivioMD scores highest on state availability and ease of access.

What the plan covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

VivioMD is a telehealth weight-management service that does sell GLP-1 treatment, but publishes no price on any public page. Its homepage promises flat pricing that never goes up as your dose increases, a full refund if you are not approved, cancellation with no fees, and HSA/FSA eligibility, with clinicians from OpenLoop Healthcare Partners P.C. and medication from independent state-licensed pharmacies. It names no medication anywhere, offering only 'top GLP-1 treatments — brand-name and personalized options'.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to VivioMD

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
VivioMD logo
3.6 / 5
Our editorial rating
Visit VivioMD →

VivioMD at a glance

Type
GLP-1 telehealth provider
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
1 FDA warning letter on record; see below

How we scored VivioMD

Each dimension is scored algorithmically from VivioMD'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.0/10

VivioMD does not post a standard monthly cash price up front, so cost transparency is limited. Confirm the ongoing rate before you commit.

Effectiveness25%

6.2/10

VivioMD does not name the medications its program uses, so there is no published medication lineup to assess. Ask which drug you would be prescribed before you start.

User Experience15%

7.8/10

Online intake and platform experience (consult included in the price); 0 platform features disclosed.

Trust & Safety15%

6.8/10

Key details fully confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).

Accessibility10%

9.0/10

VivioMD treats patients in all 50 states.

Support10%

6.6/10

VivioMD provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this VivioMD review

Last checked November 2026
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

FDA warning-letter register
An active letter is on file for this provider; see below

What to expect when you sign up with VivioMD

We walked VivioMD's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Complete an online health assessment.
  2. 2A licensed provider reviews your evaluation (an online evaluation; no video visit stated).
  3. 3If approved, medication is delivered to your door.
Price shown only after intake
  • The public site names no medication at all (only 'top GLP-1 treatments'), and the intake asks injection or dissolvable tablet without naming a drug.
  • Described as an 'online evaluation'; no video visit explicitly required.
  • Discloses compounded meds are not FDA-approved.
  • No monthly price is displayed on the homepage, no pricing page exists, and 24 intake screens show no figure either.
  • Clinicians are named as OpenLoop Healthcare Partners P.C., and the pharmacies only as 'independent, state-licensed U.S. compounding and retail pharmacies'.

VivioMD customer support

Hours
24/7 messaging with care team

What we like

  • Flat pricing: the site says the cost never goes up as your dose increases
  • Full refund if you are not approved, and cancellation with no fees
  • HSA and FSA eligible, with clinicians named as OpenLoop Healthcare Partners P.C.
  • Licensed providers claimed in all 50 states

Watch-outs

  • Publishes no price on any public page, and two dozen intake screens show none either
  • Names no medication anywhere; the site offers only 'top GLP-1 treatments'
  • Dispensing pharmacies are described only as 'independent, state-licensed' and are never named
  • Received an FDA warning letter in June 2026 over false or misleading claims about compounded GLP-1 products

VivioMD: a 50-state telehealth program that won't show you a price

VivioMD is a nationwide telehealth wellness service that markets a physician-supervised weight program with the medication, the provider consult, and shipping all rolled into one plan. The pitch is simplicity: board-certified, U.S.-licensed clinicians who can see patients in all 50 states, with treatment mailed to your door. That broad licensing footprint is useful if you live somewhere most compounding-focused telehealth brands skip. But VivioMD publishes no price anywhere on its public site, so know that before you sign up.

Where the price is, and where it isn't

VivioMD's homepage sells the program hard (a summer promotion banner of a hundred dollars off plus free shipping, “Flat pricing — never goes up as your dose increases,” a five-minute assessment), but it never prints a monthly figure, and there is no pricing page. The number appears only inside the sign-up flow, after a long run of health questions. Confirm the exact plan, drug, and monthly cost inside VivioMD's intake before you pay.

How the pricing model works

VivioMD uses an all-inclusive monthly structure rather than charging separately for the visit, the prescription, and delivery. The medication, a live provider consult, and free shipping are bundled into the plan price, so the number you see is meant to be the number you pay, with no surprise consult fee stacked on top. That bundling is a plus for budgeting, because it removes the membership-plus-pharmacy math that trips people up elsewhere.

VivioMD also promises the price will not rise as your dose does, that HSA and FSA cards are accepted, that you can cancel anytime with no fees, and that you get a full refund if a provider does not approve you. Those are useful terms, but without a published figure you can't weigh them against anyone else's until you're most of the way through the intake. For comparison, the category median across the providers we track is $179 a month. See our scoring methodology for how we weigh price against everything else.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

Medications and how they're dispensed

The public site names no medication. It offers “top GLP-1 treatments — brand-name and personalized options,” and its footer lists Wegovy, Ozempic, Mounjaro, and Zepbound only as trademarks it is not affiliated with, alongside a note that a provider may prescribe a compounded medication. So before the intake you will not know if the offer is compounded semaglutide, compounded tirzepatide, or a brand pen. About two dozen screens into the intake, the quiz asks whether you'd rather take a weekly injection or a daily dissolvable tablet, and whether you care more about price or potency, still without naming a drug or a dollar figure. MEDVi shows its compounded injection and tablet prices before you start, alongside brand-name Wegovy and Zepbound. Prescribing is done by clinicians from OpenLoop Healthcare Partners P.C., and medication ships from independent, state-licensed compounding and retail pharmacies with delivery included.

One caution: compounded GLP-1 medicines are not FDA-approved products; they're prepared by compounding pharmacies and aren't reviewed the way brand drugs are. VivioMD does not publish the specific compounding pharmacy or its accreditation. Lean Meds uses the same OpenLoop medical group. It names its four dispensing pharmacies, with addresses. If pharmacy sourcing matters to you (and for an injectable it should), ask VivioMD which pharmacy fills your prescription and whether it's state-licensed and accredited before your first shipment.

Reach and an all-in-one plan

VivioMD's first strength is reach. It leans hard on its claim of licensed providers in all 50 states, and plenty of telehealth weight programs exclude a handful of states, leaving patients in those gaps stuck. If you've been turned away elsewhere because of where you live, a provider built around nationwide coverage is one to consider.

The second is the all-in-one experience: one price, a live provider consult attached to every plan, free shipping, and 24/7 messaging with a care team. Add the refund-if-not-approved promise and there is little financial risk in finding out what the price is.

Who should choose it

  • You live in a state where other telehealth GLP-1 programs won't prescribe and you need broad licensing
  • You want one bundled monthly price with the consult and shipping included, not itemized add-ons
  • You'd rather answer the health questions first and see the price afterward than the other way around
  • You'd consider brand-name Ozempic and accept its much higher list price; if a brand pen is the plan from the start, Push Health routes Ozempic, Zepbound and Mounjaro prescriptions through a large pharmacy network, though it publishes little about pricing

Who should skip it

  • You want to see a price before you answer health questions, since VivioMD shows one only inside the intake
  • You need full transparency on the compounding pharmacy and its accreditation up front
  • You want to know which molecule you'll be offered before you start (the public site names none)
  • You'd rather use a provider the FDA has never written to; VivioMD drew a warning letter in June 2026

Trust, safety, and medical oversight

FDA sent VivioMD Group LLC a warning letter in June 2026, headed false and misleading claims / misbranded, over the compounded semaglutide and tirzepatide it sells; the full notice is further down this page. On the positive side, the program is physician-supervised with a live consult built into every plan, and the footer links to a LegitScript check. The weak spot is transparency: no named compounding partner, no published medication list, and no published price. None of that means VivioMD is unsafe; it means you should confirm more inside the intake than you would with a fully transparent provider.

Bottom line

VivioMD offers nationwide licensing, an all-inclusive bundle, a flat-price promise, and a refund if you aren't approved. But it tells you nothing about price or medication until you're deep in its intake, and it carries a June 2026 FDA letter. If broad state coverage is what you need, the five-minute assessment is a short way to find out more. Just confirm the price, the exact medication, and the filling pharmacy inside VivioMD's flow before you commit.

The Bottom Line

VivioMD scores highest on state availability and ease of access.

Score: 7.1/10Best for: flat-priced GLP-1 care with a refund if you are not approved

Ready to start with VivioMD?

See current pricing and start your online intake.

VivioMD might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Frequently Asked Questions

VivioMD is a telehealth wellness provider that connects patients with board-certified, U.S.-licensed clinicians for weight-management care, including GLP-1 medications. It uses a short online health assessment reviewed by a licensed provider, with medication shipped from a licensed pharmacy. It's a real service, but as with any compounded GLP-1 program, confirm that treatment is appropriate for you with the prescribing clinician.
Yes, VivioMD sells GLP-1 treatment, but it does not say which one. The public site offers 'top GLP-1 treatments — brand-name and personalized options' and names no molecule; the intake eventually asks whether you want an injection or a dissolvable tablet, still without naming a drug. Which option fits you is decided with a licensed provider, and the site notes that compounded products are not FDA-approved.
VivioMD publishes no price. There is no pricing page, no figure on the homepage, and no figure across two dozen intake screens, so the only promise you can hold it to is flat pricing that 'never goes up as your dose increases' plus a summer promotion advertised as $100 off with free shipping. Expect to learn the cost at checkout. No insurance is required, and HSA and FSA cards are accepted.
The public site names none. It advertises 'brand-name and personalized options' and offers a choice between an injection and a dissolvable tablet inside the intake, but no molecule is printed anywhere a shopper can read it before signing up. Your clinician selects the medication based on your health profile, so ask which one you are being prescribed.
The homepage says 'Licensed Providers in All 50 States'. Eligibility for a specific medication is confirmed during the online intake, and availability can change, so confirm your state at signup.
You complete a roughly 3-minute online health assessment, a licensed provider reviews your information (often the same day), and if a GLP-1 is prescribed, the medication ships to your door from a licensed pharmacy. No insurance is required, and it accepts major cards, Apple Pay, Google Pay, and HSA/FSA funds. A prescription is only issued if a clinician determines it's appropriate for you.
VivioMD doesn't use a typed coupon code. When we last checked (June 2026), its site said: $100 Off First Month. Confirm the current offer on VivioMD's own checkout via the link on this page; third-party "VivioMD promo code" sites are typically fake.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: Publishes no price on any public page, and two dozen intake screens show none either; names no medication anywhere; the site offers only 'top GLP-1 treatments'; dispensing pharmacies are described only as 'independent, state-licensed' and are never named.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

VivioMD received an FDA warning letter dated June 8, 2026

The letter concerns false and misleading claims and misbranded drugs (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this VivioMD review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.

See VivioMD's current pricing

Start the online intake to check eligibility and today's price.